The BriefBrief · Intelligence, not news.
Download on the App Store Get it on Google Play
Top Stories World US Deutschland Россия Sports Business Weather Local Messages My Briefs
Event Brief
Apr 2, 2026 at 10:02 AM ET

Wegovy Pill Outperforms Lilly’s Oral GLP-1 in Study

By The BriefBrief
Novo Nordisk claims Wegovy shows greater weight loss than Lilly's Foundayo in a recent cross-trial comparison.
WHO: Novo Nordisk
WHAT: Wegovy pill outperforms Lilly’s oral GLP-1
WHEN: Apr 2, 2026 at 8:00 AM ET
WHERE: Denmark
WHY: Novo's findings evaluated previously published studies of the medicines.
Sources (2): CNBC Top News, MarketWatch

How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.

Know more. Read less.

The BriefBrief — updated continuously, every category, every day.
Saudi Arabia delays response to UAE leaving Opec
Saudi Arabia May 1, 2026 at 3:23 PM ET
Amazon faces months of repairs after drone strikes
Amazon May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota May 1, 2026 at 3:23 PM ET

Page 21430 of 21430

Same format. Every time.

Continue reading — sign in or create a free account with

G Google  Apple or email